Skip to main content Accessibility help
×
Home
  • Print publication year: 2019
  • Online publication date: October 2019

Chapter 4 - Classifications of Seizures and Epilepsies

Summary

Epilepsy is amongst the most common of neurological disorders seen in children, with incidence rates ranging from 33.3–82 cases per 100,000 per year.14 The incidence is highest in the first year of life, and decreases in the teen years. Epilepsy is clearly focal in onset in approximately two-thirds of pediatric cases and generalized in onset in one-quarter.4 Approximately half of children have no known etiology.4

1.Adelow, C, Andell, E, Amark, P, et al. Newly diagnosed single unprovoked seizures and epilepsy in Stockholm, Sweden: first report from the Stockholm Incidence Registry of Epilepsy (SIRE). Epilepsia. 2009;50(5):10941101.
2.Camfield, CS, Camfield, PR, Gordon, K, Wirrell, E, Dooley, JM. Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia. 1996;37(1):1923.
3.Freitag, CM, May, TW, Pfafflin, M, Konig, S, Rating, D. Incidence of epilepsies and epileptic syndromes in children and adolescents: a population-based prospective study in Germany. Epilepsia. 2001;42(8):979985.
4.Wirrell, EC, Grossardt, BR, Wong-Kisiel, LC, Nickels, KC. Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: a population-based study. Epilepsy Res. 2011;95(1–2):110118.
5.Brorson, LO, Wranne, L. Long-term prognosis in childhood epilepsy: survival and seizure prognosis. Epilepsia. 1987;28(4):324330.
6.Camfield, P, Camfield, C. Childhood epilepsy: what is the evidence for what we think and what we do? J Child Neurol. 2003;18(4):272287.
7.Sillanpaa, M, Schmidt, D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain. 2006;129(Pt 3):617624.
8.Berg, AT, Rychlik, K, Levy, SR, Testa, FM. Complete remission of childhood-onset epilepsy: stability and prediction over two decades. Brain. 2014;137(Pt 12):32133222.
9.Wirrell, EC, Wong-Kisiel, LC, Mandrekar, J, Nickels, KC. What predicts enduring intractability in children who appear medically intractable in the first 2 years after diagnosis? Epilepsia. 2013;54(6):10561064.
10.Berg, AT, Shinnar, S, Levy, SR, et al. Defining early seizure outcomes in pediatric epilepsy: the good, the bad and the in-between. Epilepsy Res. 2001;43(1):7584.
11.Arts, WF, Geerts, AT, Brouwer, OF, et al. The early prognosis of epilepsy in childhood: the prediction of a poor outcome. The Dutch study of epilepsy in childhood. Epilepsia. 1999;40(6):726734.
12.Berg, AT, Langfitt, J, Shinnar, S, et al. How long does it take for partial epilepsy to become intractable? Neurology. 2003;60(2):186190.
13.Spooner, CG, Berkovic, SF, Mitchell, LA, Wrennall, JA, Harvey, AS. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology. 2006;67(12):21472153.
14.Camfield, P, Camfield, C. Long-term prognosis for symptomatic (secondarily) generalized epilepsies: a population-based study. Epilepsia. 2007;48(6):11281132.
15.Camfield, C, Camfield, P. Twenty years after childhood-onset symptomatic generalized epilepsy the social outcome is usually dependency or death: a population-based study. Dev Med Child Neurol. 2008;50(11):859863.
16.Dhamija, R, Moseley, BD, Cascino, GD, Wirrell, EC. A population-based study of long-term outcome of epilepsy in childhood with a focal or hemispheric lesion on neuroimaging. Epilepsia. 2011;52(8):15221526.
17.Berg, AT, Testa, FM, Levy, SR. Complete remission in nonsyndromic childhood-onset epilepsy. Ann Neurol. 2011;70(4):566573.
18.Wirrell, EC, Grossardt, BR, So, EL, Nickels, KC. A population-based study of long-term outcomes of cryptogenic focal epilepsy in childhood: cryptogenic epilepsy is probably not symptomatic epilepsy. Epilepsia. 2011;52(4):738745.
19.Wirrell, E, Camfield, C, Camfield, P, Dooley, J. Prognostic significance of failure of the initial antiepileptic drug in children with absence epilepsy. Epilepsia. 2001;42(6):760763.
20.Camfield, CS, Camfield, PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology. 2009;73(13):10411045.
21.Wirrell, EC. Benign epilepsy of childhood with centrotemporal spikes. Epilepsia. 1998;39(Suppl 4):S32–41.
22.Chiron, C, Marchand, MC, Tran, A, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO Study Group. Lancet. 2000;356(9242):16381642.
23.Howell, KB, McMahon, JM, Carvill, GL, et al. SCN2A encephalopathy: a major cause of epilepsy of infancy with migrating focal seizures. Neurology. 2015;85(11):958966.
24.Pearl, PL. Amenable treatable severe pediatric epilepsies. Semin Pediatr Neurol. 2016;23(2):158166.
25.Toledano, M, Britton, JW, McKeon, A, et al. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology. 2014;82(18):15781586.
26.Berg, AT, Zelko, FA, Levy, SR, Testa, FM. Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes: a prospective cohort study. Neurology. 2012;79(13):13841391.
27.Bombardieri, R, Pinci, M, Moavero, R, Cerminara, C, Curatolo, P. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. Eur J Paediatr Neurol. 2010;14(2):146149.
28.Cusmai, R, Moavero, R, Bombardieri, R, Vigevano, F, Curatolo, P. Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. Epilepsy Behav. 2011;22(4):735739.
29.Shrivastava, A, Kumar, A, Thomas, JD, et al. Association of acute toxic encephalopathy with litchi consumption in an outbreak in Muzaffarpur, India, 2014: a case-control study. Lancet Glob Health. 2017;5(4):e458e466.
30.Torres, JR, Falleiros-Arlant, LH, Duenas, L, et al. Congenital and perinatal complications of chikungunya fever: a Latin American experience. Int J Infect Dis. 2016;51:8588.
31.Gastaut, H. Classification of the epilepsies: proposal for an international classification. Epilepsia. 1969;10(Suppl):1421.
32.Gastaut, H. Clinical and electroencephalographical classification of epileptic seizures. Epilepsia. 1970;11(1):102113.
33.Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22(4):489501.
34.Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989;30(4):389399.
35.Berg, AT, Berkovic, SF, Brodie, MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51(4):676685.
36.Engel, J Jr. Report of the ILAE classification core group. Epilepsia. 2006;47(9):15581568.
37.Fisher, RS, Cross, JH, French, JA, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522530.
38.Scheffer, IE, Berkovic, S, Capovilla, G, et al. ILAE classification of the epilepsies: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512521.
39.Scheffer, IE, French, J, Hirsch, E, et al. Classification of the epilepsies: new concepts for discussion and debate – Special Report of the ILAE Classification Task Force of the Commission for Classification and Terminology. Epilepsia Open. 2016;1(1–2):3744.
40.Fisher, RS, Cross, JH, D’Souza, C, et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017;58(4):531542.
41.Berg, AT, Scheffer, IE. New concepts in classification of the epilepsies: entering the 21st century. Epilepsia. 2011;52(6):10581062.
42.Blumenfeld, H, Meador, KJ. Consciousness as a useful concept in epilepsy classification. Epilepsia. 2014;55(8):11451150.
43.Luders, H, Amina, S, Bailey, C, et al. Proposal: different types of alteration and loss of consciousness in epilepsy. Epilepsia. 2014;55(8):11401144.
44.Blume, WT, Luders, HO, Mizrahi, E, et al. Glossary of descriptive terminology for ictal semiology: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42(9):12121218.
45.Seneviratne, U, Cook, M, D’Souza, W. Focal abnormalities in idiopathic generalized epilepsy: a critical review of the literature. Epilepsia. 2014;55(8):11571169.
46.Lombroso, CT. Consistent EEG focalities detected in subjects with primary generalized epilepsies monitored for two decades. Epilepsia. 1997;38(7):797812.
47.Ferrie, CD. Idiopathic generalized epilepsies imitating focal epilepsies. Epilepsia. 2005;46(Suppl 9):9195.
48.Holmes, MD, Brown, M, Tucker, DM. Are “generalized” seizures truly generalized? Evidence of localized mesial frontal and frontopolar discharges in absence. Epilepsia. 2004;45(12):15681579.
49.Yeh, SB, Schenck, CH. Sporadic nocturnal frontal lobe epilepsy: A consecutive series of 8 cases. Sleep Sci. 2014;7(3):170177.
50.Oldani, A, Zucconi, M, Ferini-Strambi, L, Bizzozero, D, Smirne, S. Autosomal dominant nocturnal frontal lobe epilepsy: electroclinical picture. Epilepsia. 1996;37(10):964976.
51.Tinuper, P, Bisulli, F. From nocturnal frontal lobe epilepsy to sleep-related hypermotor epilepsy: a 35-year diagnostic challenge. Seizure. 2017;44:8792.
52.O’Callaghan, FJ, Edwards, SW, Alber, FD, et al. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol. 2017;16(1):3342.
53.Montouris, GD, Wheless, JW, Glauser, TA. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome. Epilepsia. 2014;55(Suppl 4):1020.
54.Riikonen, R. Long-term otucome of West syndrome: a study of adults with a history of infantile spasms. Epilepsia. 1996;37(4):367372.
55.Genton, P, Velizarova, R, Dravet, C. Dravet syndrome: the long-term outcome. Epilepsia. 2011;52(Suppl 2):4449.
56.Kim, HJ, Kim, HD, Lee, JS, et al. Long-term prognosis of patients with Lennox-Gastaut syndrome in recent decades. Epilepsy Res. 2015;110:1019.
57.Caraballo, RH, Chamorro, N, Darra, F, Fortini, S, Arroyo, H. Epilepsy with myoclonic atonic seizures: an electroclinical study of 69 patients. Pediatr Neurol. 2013;48(5):355362.
58.Van Bogaert, P. Epileptic encephalopathy with continuous spike-waves during slow-wave sleep including Landau-Kleffner syndrome. Handb Clin Neurol. 2013;111:635640.
59.Wirrell, EC, Camfield, CS, Camfield, PR, et al. Long-term psychosocial outcome in typical absence epilepsy: sometimes a wolf in sheeps’ clothing. Arch Pediatr Adolesc Med. 1997;151(2):152158.
60.Baykan, B, Martinez-Juarez, IE, Altindag, EA, Camfield, CS, Camfield, PR. Lifetime prognosis of juvenile myoclonic epilepsy. Epilepsy Behav. 2013;28(Suppl 1):S18–24.
61.Bouma, PA, Bovenkerk, AC, Westendorp, RG, Brouwer, OF. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology. 1997;48(2):430437.
62.Camfield, CS, Camfield, PR. Rolandic epilepsy has little effect on adult life 30 years later: a population-based study. Neurology. 2014;82(13):11621166.
63.Caraballo, R, Cersosimo, R, Medina, C, Fejerman, N. Panayiotopoulos-type benign childhood occipital epilepsy: a prospective study. Neurology. 2000;55(8):10961100.
64.Wirrell, EC, Camfield, CS, Camfield, PR, Gordon, KE, Dooley, JM. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology. 1996;47(4):912918.
65.Allen, NM, Mannion, M, Conroy, J, et al. The variable phenotypes of KCNQ-related epilepsy. Epilepsia. 2014;55(9):e99105.
66.Kato, M, Yamagata, T, Kubota, M, et al. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation. Epilepsia. 2013;54(7):12821287.
67.Weckhuysen, S, Mandelstam, S, Suls, A, et al. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol. 2012;71(1):1525.
68.Nordli, DR Jr., De Vivo, DC. Classification of infantile seizures: implications for identification and treatment of inborn errors of metabolism. J Child Neurol. 2002;17(Suppl 3):3S3–7; discussion 3S8.
69.Campbell, C, Levin, S, Humphreys, P, Walop, W, Brannan, R. Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature. BMC Pediatr. 2005;5(1):47.
70.Vezzani, A, Fujinami, RS, White, HS, et al. Infections, inflammation and epilepsy. Acta Neuropathol. 2016;131(2):211234.
71.Britton, JW. Autoimmune epilepsy. In: Pittock, SJ, Vincent, A, eds., Handbook of Clinical Neurology. Vol 133. Cambridge, MA: Elsevier; 2016:219245.
72.Suleiman, J, Dale, RC. The recognition and treatment of autoimmune epilepsy in children. Dev Med Child Neurol. 2015;57(5):431440.
73.Jensen, FE. Epilepsy as a spectrum disorder: implications from novel clinical and basic neuroscience. Epilepsia. 2011;52(Suppl 1):16.
74.Fisher, RS, van Emde, Boas W, Blume, W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46(4):470472.
75.Ismayilova, V, Demir, AU, Tezer, FI. Subjective sleep disturbance in epilepsy patients at an outpatient clinic: a questionnaire-based study on prevalence. Epilepsy Res. 2015;115:119125.
76.Nickels, KC, Zaccariello, MJ, Hamiwka, LD, Wirrell, EC. Cognitive and neurodevelopmental comorbidities in paediatric epilepsy. Nat Rev Neurol. 2016;12(8):465476.